Literature DB >> 17661839

A case report of syndrome of inappropriate secretion of antidiuretic hormone with marked edema due to administration of hypertonic saline.

Hiroto Maeda1, Kazuhiko Tsuruya, Hideki Yotsueda, Masatomo Taniguchi, Masanori Tokumoto, Hideki Hirakata, Mitsuo Iida.   

Abstract

A 61-year-old man had hyponatremia (serum Na 112 mmol/L), which was associated with disturbance of consciousness. Therefore, administration of hypertonic saline was commenced. Eventually he was diagnosed with the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Hypertonic saline was continued for 45 days, and plasma Na concentration rose to 138 mmol/L. At that time we were consulted regarding further administration of hypertonic saline. At the time of the consultation marked edema had developed affecting the whole body. The cardiothoracic ratio was increased and pleural effusion was evident on the chest X-ray. Administration of hypertonic saline was discontinued to prevent further worsening of the edema. Furthermore, water restriction (500 mL/day) was started. Body weight decreased by 4.3 kg in 7 days and the edema was diminished. However, plasma Na concentration decreased to 117 mmol/L. At that stage, we needed to balance the treatment of hyponatremia to the increased extracellular fluid volume (ECF). To normalize the ECF, we carried out ultrafiltration (UF) three times. Resolution of edema by using an extracorporeal UF method allowed the control of plasma Na concentration. In this case increased ECF volume hindered the adjustment of plasma Na concentration. The infusion of hypertonic saline is now used commonly by physicians. It is necessary to consider the potential risks of such treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17661839     DOI: 10.1111/j.1744-9987.2007.00469.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  5 in total

Review 1.  Modern approaches to pediatric brain injury therapy.

Authors:  Peter A Walker; Matthew T Harting; James E Baumgartner; Stephen Fletcher; Nathan Strobel; Charles S Cox
Journal:  J Trauma       Date:  2009-08

Review 2.  Paraneoplastic syndromes in olfactory neuroblastoma.

Authors:  Michał Kunc; Anna Gabrych; Piotr Czapiewski; Krzysztof Sworczak
Journal:  Contemp Oncol (Pozn)       Date:  2015-03-26

3.  Correlating the treatment outcome with tumor staging, grading, and various treatment modalities in patients with esthesioneuroblastoma.

Authors:  Shuchita Singh; Lavleen Singh; Richa Ranjan; Manoj Kumar Singh; Alok Thakar; Suresh Chandra Sharma
Journal:  South Asian J Cancer       Date:  2019 Apr-Jun

4.  Low-Grade Esthesioneuroblastoma Presenting as SIADH: A Review of Atypical Manifestations.

Authors:  Andrew Senchak; Judy Freeman; Douglas Ruhl; Jordan Senchak; Christopher Klem
Journal:  Case Rep Otolaryngol       Date:  2012-12-04

5.  An Uncommon Case of Pediatric Esthesioneuroblastoma Presenting as SIADH: 18F-FDG PET/CT in Staging and Post-Therapeutic Assessment.

Authors:  Marie Øbro Fosbøl; Anders Bilde; Jeppe Friborg; Eric von Benzon; Andreas Kjær; Christian von Buchwald; Lise Borgwardt
Journal:  Diagnostics (Basel)       Date:  2018-01-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.